Galectin Therapeutics

Galectin Therapeutics is a leading pharmaceutical company dedicated to developing innovative therapies for fibrotic disease and cancer. With a focus on galectin science and drug development, Galectin Therapeutics utilizes its unique carbohydrate technology to target galectin proteins, which play a crucial role in biologic and pathologic functions. The company is committed to addressing diseases with serious, life-threatening consequences, where current treatment options are limited.

Located at 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA 30071, US, Galectin Therapeutics is actively pursuing a clear development pathway towards clinical enhancement and commercialization of its lead compounds in liver fibrosis, tumor vaccine enhancement, and colorectal cancer. The company's strategy involves establishing clinical development approaches that add value and seeking strategic partnerships to advance its programs.

Galectin Therapeutics is dedicated to improving patient outcomes through its innovative research and development efforts. The information about Galectin Therapeutics will be completed soon with the support of the company’s management. We invite the manager of Galectin Therapeutics to create a customized and exclusive company showcase and product listing on our platform.